These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2932060)

  • 41. [Survival and changes of clinical laboratory data in phase II study with 5'-DFUR].
    Taguchi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1019-29. PubMed ID: 8687216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical trial of UFT against disseminated breast cancer].
    Itoh S; Konishi Y; Harauchi D; Shinoto M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2381-5. PubMed ID: 6437344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bi-weekly chemotherapy with medium-dose docetaxel for advanced and recurrent breast cancers (The 15th study of Keiji Breast Cancer Study Group)].
    Fujino S; Kan N; Lee CJ; Inamoto T; Mise K; Sawai S; Okamoto M; Nishimura S; Hori T; Maruhashi K; Yamauchi A; Fujii K; Mitsumori M; Higashide S; Takemoto Y; Okamura T;
    Gan To Kagaku Ryoho; 2005 May; 32(5):631-5. PubMed ID: 15918562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical benefit of S-1 in metastatic breast cancer].
    Saeki T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
    Murakami S; Yamamoto Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1147-9. PubMed ID: 17637560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
    Miwa M; Sekiguchi F; Akaza H; Tokita H; Nitta K; Adachi S; Kanazawa K; Ishitsuka H
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1579-86. PubMed ID: 1831339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective].
    Kataoka T; Okamoto T; Gotoh T; Sadamoto S; Nishiki M; Dohi K
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):299-302. PubMed ID: 8434970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
    Shien T; Shimizu C; Akashi-Tanaka S; Yonemori K; Kohno T; Hojo T; Ando M; Katsumata N; Kinoshita T; Fujiwara Y
    Jpn J Clin Oncol; 2008 Mar; 38(3):172-5. PubMed ID: 18296424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer].
    Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Significance of 5'-deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers--activity of pyrimidine nucleoside phosphorylase (PyNPase) and serum immunosuppressive acidic protein (IAP)].
    Murakami N; Hirano M; Saito H; Nagao S; Arano Y; Kikuchi T; Ishikawa N; Kurokawa M; Kitsukawa H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1959-66. PubMed ID: 8978804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of recurrent colon cancer treated markedly effective with 5'-DFUR].
    Hirano M; Kato A; Murakami N; Saito H; Watanabe S; Oosawa T; Kikkawa H; Kitagawa K; Masuda S; Mori H
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1063-6. PubMed ID: 8512335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer].
    Hatae M; Noda K; Yajima A; Sato S; Terashima Y; Ochiai K; Sasaki H; Mizutani K; Honjo H; Yamamoto T; Ozaki M; Yamamoto K; Hasegawa K; Nishimura R; Kudo T; Kobashi Y; Yakushiji M; Sugiyama T; Hasuo Y; Onishi Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):705-11. PubMed ID: 9571968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)].
    Yamaguchi A; Maeda A; Hachisuka K; Yura J; Honda K; Honda H; Yoshizaki S; Tsuruga N; Nakazato H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):621-6. PubMed ID: 8154887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experimental study relating to the anti-cancer effect of doxifluridine].
    Zhao L; Kaneda T; Tohnai I; Shinoda T; Kasuya Y; Matsuyama M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1182-9. PubMed ID: 2144562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel prophylactic effect of doxifluridine in superficial bladder cancer.
    Matsuyama H; Baba Y; Shimabukuro T; Uchiyama K; Aoki A; Suga A; Jojima K; Suyama K; Yamamoto N; Naito K
    Scand J Urol Nephrol; 2004; 38(5):366-72. PubMed ID: 15764246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.